Soong T. Chiang

1.0k total citations
35 papers, 800 citations indexed

About

Soong T. Chiang is a scholar working on Pharmacology, Pharmacology and Analytical Chemistry. According to data from OpenAlex, Soong T. Chiang has authored 35 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 12 papers in Pharmacology and 8 papers in Analytical Chemistry. Recurrent topics in Soong T. Chiang's work include Pharmacogenetics and Drug Metabolism (11 papers), Analytical Methods in Pharmaceuticals (8 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Soong T. Chiang is often cited by papers focused on Pharmacogenetics and Drug Metabolism (11 papers), Analytical Methods in Pharmaceuticals (8 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Soong T. Chiang collaborates with scholars based in United States, Canada and Netherlands. Soong T. Chiang's co-authors include Steven Troy, William J. Jusko, Richard L. Rudolph, Vernon D. Parker, Karen J. Klamerus, Samuel F. Sisenwine, Kathleen Moloney, Richard J. Fruncillo, Barry R. Walker and Hans W. Ruelius and has published in prestigious journals such as The American Journal of Cardiology, Journal of Pharmaceutical Sciences and Clinical Pharmacology & Therapeutics.

In The Last Decade

Soong T. Chiang

34 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Soong T. Chiang United States 17 306 227 170 106 101 35 800
Menger Chung United States 17 262 0.9× 173 0.8× 194 1.1× 102 1.0× 87 0.9× 29 891
Barry D. Zussman United Kingdom 15 344 1.1× 218 1.0× 253 1.5× 86 0.8× 64 0.6× 20 915
Edward J. Antal United States 19 306 1.0× 280 1.2× 174 1.0× 165 1.6× 67 0.7× 50 1.2k
Robert A. Ronfeld United States 18 236 0.8× 260 1.1× 89 0.5× 148 1.4× 82 0.8× 29 1.0k
J. Van Harten Netherlands 17 315 1.0× 242 1.1× 312 1.8× 210 2.0× 113 1.1× 34 1.1k
Robert L. Wolen United States 15 362 1.2× 181 0.8× 195 1.1× 92 0.9× 94 0.9× 37 1.0k
H. Friedman United States 24 341 1.1× 227 1.0× 204 1.2× 156 1.5× 67 0.7× 53 1.3k
Frans M. Belpaire Belgium 19 312 1.0× 211 0.9× 112 0.7× 117 1.1× 79 0.8× 52 1.3k
Markku Anttila Finland 22 213 0.7× 273 1.2× 91 0.5× 107 1.0× 91 0.9× 41 1.4k
J S Harmatz United States 16 192 0.6× 336 1.5× 228 1.3× 173 1.6× 52 0.5× 22 1.0k

Countries citing papers authored by Soong T. Chiang

Since Specialization
Citations

This map shows the geographic impact of Soong T. Chiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soong T. Chiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soong T. Chiang more than expected).

Fields of papers citing papers by Soong T. Chiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soong T. Chiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soong T. Chiang. The network helps show where Soong T. Chiang may publish in the future.

Co-authorship network of co-authors of Soong T. Chiang

This figure shows the co-authorship network connecting the top 25 collaborators of Soong T. Chiang. A scholar is included among the top collaborators of Soong T. Chiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soong T. Chiang. Soong T. Chiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Meng, Parviz Mojaverian, Emil T. Lin, et al.. (2001). Bioavailability of amiodarone tablets administered with and without food in healthy subjects. The American Journal of Cardiology. 87(4). 432–435. 54 indexed citations
2.
Boni, Joseph, et al.. (2000). Chiral Bioequivalence. Clinical Pharmacokinetics. 39(6). 459–469. 9 indexed citations
3.
Troy, Steven, Richard L. Rudolph, Michael Mayersohn, & Soong T. Chiang. (1998). The Influence of Cimetidine on the Disposition Kinetics of the Antidepressant Venlafaxine. The Journal of Clinical Pharmacology. 38(5). 467–474. 12 indexed citations
4.
Troy, Steven, et al.. (1997). Pharmacokinetic and Pharmacodynamic Evaluation of the Potential Drug Interaction Between Venlafaxine and Ethanol. The Journal of Clinical Pharmacology. 37(11). 1073–1081. 7 indexed citations
5.
Troy, Steven, et al.. (1997). Pharmacokinetics and Effect of Food on The Bioavailability of Orally Administered Venlafaxine. The Journal of Clinical Pharmacology. 37(10). 954–961. 29 indexed citations
6.
Troy, Steven, et al.. (1996). Pharmacokinetic Interaction Between Multiple‐Dose Venlafaxine and Single‐Dose Lithium. The Journal of Clinical Pharmacology. 36(2). 175–181. 20 indexed citations
7.
Fruncillo, Richard J., Steven Troy, Vernon D. Parker, et al.. (1996). Pharmacokinetics of the aldose reductase inhibitor tolrestat: Studies in healthy young and elderly male and female subjects and in subjects with diabetes. Clinical Pharmacology & Therapeutics. 59(6). 603–612. 4 indexed citations
8.
Klamerus, Karen J., Vernon D. Parker, Richard L. Rudolph, Albert Derivan, & Soong T. Chiang. (1996). Effects of Age and Gender on Venlafaxine and O‐Desmethylvenlafaxine Pharmacokinetics. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 16(5). 915–923. 41 indexed citations
9.
Jusko, William J., et al.. (1995). Tolrestat pharmacokinetic and pharmacodynamic effects on red blood cell sorbitol levels in normal volunteers and in patients with insulin-dependent diabetes*. Clinical Pharmacology & Therapeutics. 58(6). 631–640. 16 indexed citations
10.
Troy, Steven, Vernon D. Parker, Richard J. Fruncillo, & Soong T. Chiang. (1995). The Pharmacokinetics of Venlafaxine When Given in a Twice‐Daily Regimen. The Journal of Clinical Pharmacology. 35(4). 404–409. 62 indexed citations
11.
Troy, Steven, et al.. (1995). The Dose Proportionality of the Pharmacokinetics of Ardeparin, a Low Molecular Weight Heparin, in Healthy Volunteers. The Journal of Clinical Pharmacology. 35(12). 1194–1199. 6 indexed citations
12.
Troy, Steven, Robert W. Schultz, Vernon D. Parker, Soong T. Chiang, & Robert A. Blum. (1994). The effect of renal disease on the disposition of venlafaxine. Clinical Pharmacology & Therapeutics. 56(1). 14–21. 44 indexed citations
13.
Troy, Steven, David Hicks, M. Kraml, Kenneth A. Conrad, & Soong T. Chiang. (1992). The effect of renal disease on tolrestat pharmacokinetics. Clinical Pharmacology & Therapeutics. 51(3). 271–277. 3 indexed citations
14.
Klamerus, Karen J., Kathleen Moloney, Richard L. Rudolph, et al.. (1992). Introduction of a Composite Parameter to the Pharmacokinetics of Venlafaxine and its Active O‐Desmethyl Metabolite. The Journal of Clinical Pharmacology. 32(8). 716–724. 170 indexed citations
15.
Troy, Steven, et al.. (1991). The Absolute Bioavailability and Dose Proportionality of Intravenous and Oral Dosage Regimens of Recainam. The Journal of Clinical Pharmacology. 31(5). 433–439.
16.
Stanczyk, Frank Z., et al.. (1990). Pharmacokinetic comparison of two triphasic oral contraceptive formulations containing levonorgestrel and ethinylestradiol. Contraception. 41(1). 39–53. 15 indexed citations
17.
Chiang, Soong T., et al.. (1984). Oxaprozin Dose Proportionality. The Journal of Clinical Pharmacology. 24(11). 515–522. 10 indexed citations
18.
Lasseter, Kenneth C., et al.. (1984). Pharmacokinetics of Guanabenz in Patients with Impaired Liver Function. Journal of Cardiovascular Pharmacology. 6. S766–770. 8 indexed citations
19.
Chiang, Soong T., et al.. (1982). Dose-Dependent Pharmacokinetics of the Antihypertensive 2,3,4,4a-Tetrahydro-lH-pyrazino[l,2a]quinoxalin-5-(6H)-one in Dogs and Rats. Journal of Pharmaceutical Sciences. 71(4). 414–417. 2 indexed citations
20.
Janssen, Frank W., et al.. (1980). Metabolism and kinetics of oxaprozin in normal subjects. Clinical Pharmacology & Therapeutics. 27(3). 352–362. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Menger Chung Breakdown of academic impact, for papers by Barry D. Zussman Breakdown of academic impact, for papers by Edward J. Antal Breakdown of academic impact, for papers by Robert A. Ronfeld Breakdown of academic impact, for papers by J. Van Harten Breakdown of academic impact, for papers by Robert L. Wolen Breakdown of academic impact, for papers by H. Friedman Breakdown of academic impact, for papers by Frans M. Belpaire Breakdown of academic impact, for papers by Markku Anttila Breakdown of academic impact, for papers by J S Harmatz
Rankless by CCL
2026